← The Wire
PLXNYSE
Protalix BioTherapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1006281
Develops and commercializes plant cell-based protein therapeutics for rare diseases, including enzyme replacement therapies
$168M
Market cap
$2.35
Last close
+2.2%
1D
+8.8%
5D
541K
Volume
Price · last 39 sessions+10.3%
May 4L $1.90 · H $2.35Jun 29
534
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
424B5424B5Aug 22, 2025424B5424B5Mar 17, 2025424B5424B5Feb 27, 2023424B5424B5May 2, 2022424B5424B5Jul 2, 2021424B5424B5Jul 2, 2021424B5424B5Feb 16, 2021424B5424B5Feb 11, 2021424B5424B5Oct 1, 2020424B5424B5Feb 16, 2012424B5424B5Feb 15, 2012424B5424B5Mar 18, 2011424B5424B5Mar 17, 2011424B5FINAL PROSPECTUS SUPPLEMENT MATERIALSOct 25, 2007424B5PRELIMINARY MATERIALSOct 5, 2007
Insider Activity
In the 90 days to Dec 19, 2025: 1 insider bought $101K · 1 sold $314.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Bashan DrorPRESIDENT AND CEO | Buy | 56,000 | $1.81 | $101K |
| Nov 18, 2025 | Bar-Shalev AmosDirector | Sell | 168 | $1.87 | $314 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance